Engineers Built Biohybrid Mesh to Power Medical Implants

The research-stage device converts mechanical energy from human cells into electricity to replace bulky batteries.

Updated on Oct. 7, 2026 in Energy

A magnified view of a thin, translucent polymer mesh with delicate metallic ribbons, showing the complex interface of biohybrid technology. — Engineers at the University of Massachusetts Amherst have developed an ultrathin biohybrid mesh that generates electricity directly from human cardiac cells to power medical devices. AI Illustration. Upload story photo >

Live Poll

Would you feel comfortable using a medical implant that integrates electronics directly into your human cells?

Researchers at the University of Massachusetts Amherst have developed an ultrathin biohybrid mesh that integrates electronics with human cardiac cells. The system, detailed in Science Advances, generates power directly from living cells.

Why it matters

This development aims to move medical electronics, such as pacemakers and defibrillators, away from relying on centralized, short-lived batteries. It introduces a distributed power model that leverages biological systems to sustain long-term implantable technology.

The device features ribbons of lead zirconate titanate—a ceramic material capable of converting mechanical energy into electrical charge—placed on an ultrathin polymer platform. It demonstrated a power density 10 times greater than traditional centralized sources.

The players

University of Massachusetts Amherst

A research university where engineers developed this biohybrid mesh as part of their work in implantable device technology.

The details

Engineers seeded the polymer platform with human cardiac cells, which grew into the structure to create a functional biohybrid interface. The device operates by harvesting the mechanical motion of these muscle cells and converting that energy into electricity using the integrated lead zirconate titanate ribbons. This approach aims to provide a sustainable power supply for medical devices by embedding energy generation directly into the biological tissue environment.

October 7, 2026: The study was published in the journal Science Advances.

The Tech Race

This work represents a move away from the current standard of bulky chemical batteries in medical implants. It follows a research trajectory focused on autonomous, distributed power systems that mirror the functionality of biological tissues.

This technology is currently in the research stage and not yet available for clinical use. It will eventually affect patients requiring pacemakers or defibrillators by potentially extending the lifespan of these devices and reducing the need for invasive battery replacement surgeries.

The takeaway

The team plans to stack the thin films in layers to increase power output. Watch for future studies investigating the device's longevity in animal models, which will be critical for determining the feasibility of human clinical applications.